MIDAZOLAM HYDROCHLORIDE INJECTION

The Defense Logistics Agency awarded a delivery order under contract SPE2DX25D9822 to DMS PHARMACEUTICAL GROUP INC, identified by CAGE code 1UNB0, for the procurement of three packages of MIDAZOLAM HYDROCHLORIDE INJECTION, with a total contract value of $25.50. This is a commercial item acquisition governed by FAR Part 12, utilizing standard clauses 52.212-1, 52.212-3, 52.212-4, and 52.212-5, with payment terms set at Fast Pay Net 15 and FOB destination terms under which the contractor assumes all costs and risks until delivery. The delivery is scheduled for July 16, 2026, to the USS FT LAUDERDALE (LPD 28) at FPO AE 09595, using the fastest traceable shipping method, with parcel post explicitly prohibited. Each shipment must be labeled with the transport control number and required delivery date, though specific packaging, preservation, or barcoding standards are not detailed in the provided documentation. The contractor is certified as a small business with WOSB and EDWOSB eligibility under NAICS code 325412, and the order is marked as a DPAS-rated contract, triggering associated priority and reporting obligations. The government retains inspection and acceptance responsibility at the destination, with acceptance contingent on conformity to contract requirements. Payment is processed through the Defense Finance and Accounting Service in Columbus, Ohio, with oversight provided by Contracting Officer Lorinda Ferraiolo and COTR Lisa Quinn. The acquisition is structured as a one-time delivery under a broader contract vehicle, with no options, line-item expansions, or alternate performance periods specified, reflecting a streamlined commercial procurement compliant with federal regulations and military logistics protocols.